Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
Sponsor: Vor Biopharma
Boston, MA · +46 more sites
15 recruiting rheumatoid arthritis studies with a site in Boston, MA.
Sponsor: Vor Biopharma
Boston, MA · +46 more sites
Sponsor: Novartis Pharmaceuticals
Boston, MA · +19 more sites
Sponsor: National Cancer Institute (NCI)
Boston, MA · +49 more sites
Sponsor: Amgen
Boston, MA · +17 more sites
Sponsor: University of Alabama at Birmingham
Boston, MA · Worcester, MA · +46 more sites
Sponsor: Duke University
Boston, MA · +72 more sites
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Boston, MA · +1 more sites
Sponsor: Brigham and Women's Hospital
Boston, MA
Sponsor: Sonoma Biotherapeutics, Inc.
Boston, MA · +6 more sites
Sponsor: Amgen
Boston, MA · +30 more sites
Sponsor: Sonoma Biotherapeutics, Inc.
Boston, MA · +7 more sites
Sponsor: Children's Hospital of Philadelphia
Boston, MA · +22 more sites
Sponsor: Tufts University
Boston, MA
Sponsor: Luminary Therapeutics
Boston, MA
Sponsor: Tufts Medical Center
Boston, MA
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.